The three Albion Venture Capital Trusts (VCTs) have announced the completion of their £90 million top-up offer, which is now fully subscribed. The offers, which opened on 3 November 2025, surpassed their initial £60 million target, prompting the Boards to exercise the £30 million over-allotment facility in December 2025 to meet investor demand.
The Albion VCTs provide investors with access to innovative companies in high-growth sectors, and this strong demand underscores confidence in Albion Capital’s proven investment strategy, the continued appetite among investors for exposure to the UK’s vibrant innovation pipeline, and the ability of VCTs to offer both diversification and tax-efficient returns.
The capital raised will be deployed into high-growth companies across Albion Capital’s core conviction sectors, including deeptech, healthcare, and B2B software. The Albion VCTs provide investors with access to a diversified portfolio of innovative businesses, ranging from early-stage disruptors to established scale-ups.
The fundraise follows a period of strong portfolio momentum. Over the past five years, the Albion VCTs have raised over £405 million. Over the past three years 64% of portfolio companies have advanced from the growth stage to scale-up. Notable holdings include Quantexa, the global leader in decision intelligence solutions; Oviva, Europe’s leading digital health company for weight loss, which recently raised a £200m Series D; and tem, the AI-powered infrastructure that’s cutting energy costs for businesses. Recent activity also includes significant growth rounds for deeptech and fintech innovators such as Gravity and TransFICC.
With a track record spanning 30 years, the Albion VCTs have consistently delivered value to shareholders by investing in companies with transformational growth potential. To 30 June 2025, the VCTs delivered average annual returns of 6.5% over five years and 6.9% over ten years (excluding tax relief).
Will Fraser-Allen, Managing Partner at Albion, commented:
“Reaching our £90 million hard cap, oversubscribed, reflects the growing recognition investors have that VCTs are one of the most effective ways to back the next generation of UK entrepreneurs, while targeting long-term, tax-efficient returns. In an environment where tax efficiency and long-term growth are paramount, VCTs continue to offer a compelling proposition for those looking to back British breakthroughs.
With a strong pipeline of investment opportunities across our core sectors, we are well positioned to deploy this capital into companies driving technological and scientific progress, supporting ambitious founders in sectors where the UK is a global leader, while creating value for our shareholders and the wider economy alike.”
